Amlodipine 5mg + Metoprolol Succinate 50mg ER Tablets

Amlodipine 5mg + Metoprolol Succinate 50mg combines a calcium-channel blocker with a beta blocker for high blood pressure and selected angina treatment plans. It relaxes arteries and reduces heart-rate-related cardiac workload.
Swallow the prolonged-release tablet with water at a consistent time, preferably with or after food. Do not crush or chew it. Do not abruptly discontinue the metoprolol-containing combination.
Amlodipine reduces calcium entry into arterial smooth muscle, causing vasodilation. Metoprolol blocks cardiac beta-1 receptors and slows the heart, reducing oxygen demand and workload.
Ankle swelling, flushing, headache, fatigue, dizziness and slow pulse may occur. Fainting, marked breathlessness or severe bradycardia needs assessment.
Heart block, marked hypotension and unstable decompensated heart failure affect suitability. Asthma and diabetes are relevant to beta blockade. Other rate-slowing medicines can add to bradycardia, while ankle swelling can reflect amlodipine rather than total fluid overload.
Provides complementary vessel relaxation and cardiac workload reduction in one prolonged-release combination.
No. It combines a calcium-channel blocker and beta blocker, not a water tablet.
Amlodipine alters small-vessel pressures and can cause peripheral oedema even without general fluid retention.
Yes. Metoprolol reduces heart rate; dizziness or faintness with a very slow pulse needs assessment.
It is maintenance therapy, not a rapid-acting rescue treatment for an acute chest-pain episode.
Normal pressure may reflect treatment working. Sudden beta-blocker withdrawal can also cause rebound symptoms.
Vasodilation: widening of blood vessels. Beta-1 blockade: reduction of adrenergic stimulation of the heart. Peripheral oedema: swelling in the limbs. Bradycardia: slow heart rate; AR: Amlodipine 5mg + Metoprolol Succinate 50mg أقراص ممتدة التحرر; FR: Amlodipine 5mg + Metoprolol Succinate 50mg comprimés à libération prolongée; PT: Amlodipine 5mg + Metoprolol Succinate 50mg comprimidos de libertação prolongada; ES: Amlodipine 5mg + Metoprolol Succinate 50mg comprimidos de liberación prolongada; RU: Amlodipine 5mg + Metoprolol Succinate 50mg таблетки пролонгированного высвобождения; ID: Amlodipine 5mg + Metoprolol Succinate 50mg tablet lepas lambat; VI: Amlodipine 5mg + Metoprolol Succinate 50mg viên nén giải phóng kéo dài; MS: Amlodipine 5mg + Metoprolol Succinate 50mg tablet pelepasan berpanjangan; TL: Amlodipine 5mg + Metoprolol Succinate 50mg tabletang may pinalawig na paglabas; ZH-SG: Amlodipine 5mg + Metoprolol Succinate 50mg 缓释片
International B2B Enquiry
Send a structured B2B enquiry for Amlodipine 5mg + Metoprolol Succinate 50mg ER Tablets under Cardiac Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Amlodipine 5mg + Metoprolol Succinate 50mg ER Tablets